Lineage price target lowered to $60 from $65 at Truist

Truist lowered the firm’s price target on Lineage (LINE) to $60 from $65 and keeps a Buy rating on the shares as part of a broader research note on REITs. The firm is updating its model to reflect Q1 results, recent events, and adjusted revenue growth and expense assumptions, the analyst tells investors in a research note.